Collaborative Care for Anxiety and Depression in Epilepsy

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Sep 26, 2022

Keywords

ClinConnect Summary

This clinical trial, titled "Collaborative Care for Anxiety and Depression in Epilepsy," is designed to explore a new way to help adults with epilepsy who are also experiencing anxiety and depression. The study will compare a special 24-week care program that combines neurology and mental health support with the usual care that patients typically receive. Researchers are looking for 60 adults aged 18 and older who have been diagnosed with epilepsy and show symptoms of anxiety or depression, and who are currently receiving care at Atrium Health.

Participants in this study can expect to take part in a program that aims to improve their mental health while managing their epilepsy. To be eligible, individuals must be willing to follow study procedures and provide informed consent. However, certain factors like participation in other studies, severe cognitive issues, or a recent history of severe mental health crises may exclude some patients. This trial is currently recruiting participants, and being part of it could offer new insights into effective care strategies for those facing both epilepsy and mental health challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Provision of signed and dated Informed Consent Form
• • Stated willingness to comply with all study procedures
• • Males and Females; Age \>= 18 years
• • \* Diagnosis of epilepsy: Epilepsy diagnosis based on neurology clinician impression or EEG findings
• • Anxiety or Depression symptoms
• • Receiving clinical neurological care at Atrium Health
• Exclusion Criteria:
• • Current participation in another treatment of intervention study
• • Cognitive limitations precluding completion of Anxiety and Depression self-report instruments on paper, electronically, or by interview
• • Comorbid medical condition with life expectancy less than 6 months
• * Not a good candidate for collaborative care due to:
• • Active ongoing treatment by a psychiatrist
• • Active suicidal ideation
• * History of past suicide attempt and:
• • receiving ongoing psychotherapy OR
• • has seen a psychiatrist in the past year
• * History of suicide attempt in the past year and:
• • currently prescribed 2 or more psychotropic medications for psychiatric indication (not merely as a hypnotic) AND not felt to be a good candidate for collaborative care based on the judgement of the investigators
• • Unstable drug or alcohol abuse
• • For the third Aim (sustainability supplement: intervention only care delivery exploratory study supplement) - the Participants meeting the following criteria may participate
• • individuals who meet the above INC-EXC criteria and have completed the Control Arm of a collaborative care research study - NCT05559749 - NCT05353452 or
• • individuals who meet the above INC-EXC criteria except rather than having a diagnosis of Epilepsy; they have a diagnosis of functional neurological disorder with seizures